Received Jun 2, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
second dose was given 1 year later from the first dose; This non-serious case was reported by a consumer via call center representative and described the occurrence of drug dose administration interval too long in a patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (received 1st dose on an unknown date). On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced drug dose administration interval too long (Verbatim: second dose was given 1 year later from the first dose). The outcome of the drug dose administration interval too long was not applicable. Additional Information: GSK receipt date: 28-MAY-2025 The reporter reported that someone had received only one dose of Shingrix and had forgotten to take the second dose within the recommended 2 to 6 month window, but instead received the second dose one year after the first. The reporter had a question if they need to restart the two-dose series. The patient received 2nd dose of Shingrix, later than the recommended interval, which led to lengthening of vaccination schedule.